<DOC>
	<DOC>NCT02646085</DOC>
	<brief_summary>Patients with Multiple Myeloma will undergo single timepoint Positron Emission Tomography imaging with intravenously injected C11 Methionine to detect viable lesions.</brief_summary>
	<brief_title>Multiparametric Imaging in Multiple Myeloma</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms, Plasma Cell</mesh_term>
	<mesh_term>Carbon-11 methionine</mesh_term>
	<criteria>Diagnosis of Multiple Myeloma with symptomatic bone or soft tissue disease Eastern Cooperative Oncology Group status 0 to 2 Life expectance &gt;= 12 weeks Ability to understand and willingness to sign informed consent Tissue sampling with genotype data planned within 3 months of C11 positron emission tomography (PET) imaging Pregnant or breast feeding Claustrophobic reactions and unable to lie still on a bed inside the PET scanner for 60 minutes Research related radiation exposure exceeding 50 millisieverts</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>